Comparison of Magnesium Sulfate and Dexmedetomidine as an Adjuvant to 0.5% Ropivacaine in Infraclavicular Brachial Plexus Block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201605001631245

Enrollment

105

Registered

2016-05-12

Start date

2016-05-16

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Anaesthesia

Interventions

Ropivacaine group

Magnesium sulfate group

Dexmedetomidine group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: adult patients aged, ASA I-II undergoing elective surgery in hands, wrist and forearm

Exclusion criteria

Exclusion criteria: 1- Patient refusal 2- Coagulapathy 3- Renal dysfunction 4- Hepatic dysfunction 5- Patients receiving ¿ adrenergic agonist or antagonist 6- Pregnant ladies 7- Patients with psychiatric or neurological deficit.

Design outcomes

Primary

Measure	Time frame
the duration of analgesia	—

Secondary

Measure	Time frame
onset and the duration of motor block, ;onset and the duration of sensory block;consumption of postoperative analgesia	—

Countries

Egypt

Contacts

Public ContactAhmed Essam Eldin

lecturer of anesthesiology and surgical intensive care, Tanta university

madamada6@gmail.com00201001802978

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026